BRIEF-TG Therapeutics launches first clinical trial in multiple sclerosis

* TG Therapeutics, Inc. launches first clinical trial in

multiple sclerosis (ms) for tg-1101 (ublituximab)

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more